Cara Therapeutics, Inc. (CARA)
After hours:
- Associated Press Finance
Cara: Q2 Earnings Snapshot
On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 37 cents. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
- GlobeNewswire
Cara Therapeutics Announces Exploration of Strategic Alternatives
Piper Sandler & Co. to act as financial advisorSTAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that it has engaged Piper Sandler & Co. to act as its financial advisor for the process of exploring and reviewing strategic alternatives. “We are committed to evaluating a range of strategic options to maximize value for our shareholders,” said Christopher Posner, President and Chief Executive Officer of Cara Therapeutics. “As part of this effo
